Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

ERREKA ENEA : revenue, balance sheet and financial ratios

ERREKA ENEA is a French company founded 18 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in URCUIT (64990), this company of category PME shows in 2024 a net income positive of 46 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - ERREKA ENEA (SIREN 500001615)
Indicator 2024 2023 2020 2018 2016
Revenue N/C N/C N/C N/C N/C
Net income 45 898 € 41 701 € -2 734 € 74 140 € 32 675 €
EBITDA N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, ERREKA ENEA generates positive net income of 46 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 33 k€ -> 46 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

45 898 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 172%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 34%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

172.416%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

34.112%

Solvency indicators evolution
ERREKA ENEA

Sector positioning

Debt ratio
172.42 2024
2020
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average

In 2024, the debt ratio of ERREKA ENEA (172.42) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
34.11% 2024
2020
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Average +6 pts over 3 years

In 2024, the financial autonomy of ERREKA ENEA (34.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 158.55. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

158.547

Liquidity indicators evolution
ERREKA ENEA

Sector positioning

Liquidity ratio
158.55 2024
2020
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Average +22 pts over 3 years

In 2024, the liquidity ratio of ERREKA ENEA (158.55) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of ERREKA ENEA in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of ERREKA ENEA is estimated at 640 770 € (range 446 222€ - 958 628€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
446k€ 640k€ 958k€
640 770 € Range: 446 222€ - 958 628€
NAF 5 année 2024

Valuation method used

Net Income Multiple
45 898 € × 14.0x = 640 770 €
Range: 446 222€ - 958 629€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare ERREKA ENEA with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about ERREKA ENEA

What is the revenue of ERREKA ENEA ?

The revenue of ERREKA ENEA is not publicly disclosed (confidential accounts filed with INPI).

Is ERREKA ENEA profitable?

Yes, ERREKA ENEA generated a net profit of 46 k€ in 2024.

Where is the headquarters of ERREKA ENEA ?

The headquarters of ERREKA ENEA is located in URCUIT (64990), in the department Pyrenees-Atlantiques.

Where to find the tax return of ERREKA ENEA ?

The tax return of ERREKA ENEA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does ERREKA ENEA operate?

ERREKA ENEA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.